{"id":1619,"date":"2025-06-08T11:47:33","date_gmt":"2025-06-08T11:47:33","guid":{"rendered":"https:\/\/paranddarou.co\/?p=1619"},"modified":"2025-06-09T05:21:34","modified_gmt":"2025-06-09T05:21:34","slug":"empagliflozin","status":"publish","type":"post","link":"https:\/\/paranddarou.co\/index.php\/2025\/06\/08\/empagliflozin\/","title":{"rendered":"Empagliflozin"},"content":{"rendered":"

Empagliflozin<\/span><\/h2>\n\n\n\n\n\n\n\n\n\n\n
Grade<\/strong><\/td>\nPharmaceutical<\/td>\n<\/tr>\n
Pharmacopoeia<\/strong><\/td>\nIn house<\/td>\n<\/tr>\n
CAS No.<\/strong><\/td>\n864070-44-0<\/td>\n<\/tr>\n
Product Name<\/strong><\/td>\nEmpagliflozin<\/td>\n<\/tr>\n
Chemical Name<\/strong><\/td>\n(2S,3R,4R,5S,6R)-2-[4-Chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol<\/td>\n<\/tr>\n
Function<\/strong><\/td>\nActive Pharmaceutical Ingredients (APIs)<\/td>\n<\/tr>\n
Industrial Application<\/strong><\/td>\nPharmaceutical<\/td>\n<\/tr>\n
Category<\/strong><\/td>\nAntidiabetic type 2<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

General Description<\/span><\/h3>\n

Empagliflozin is a medication used in the management and treatment of type 2 diabetes mellitus. It works in the kidneys to prevent the absorption of glucose in order to lower blood sugar levels. It is not useful for insulin-dependent or type 1 diabetes. It is also used in adults with heart failure to reduce the risk of hospitalization and death due to heart disease. It belongs to a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors.<\/p>\n

Physical Characteristics<\/span><\/h3>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Molecular formula<\/strong><\/td>\nC\u2082\u2083H\u2082\u2087ClO\u2087<\/td>\n<\/tr>\n
Molecular weight<\/strong><\/td>\n450.91<\/td>\n<\/tr>\n
Appearance<\/strong><\/td>\nWhite or off white, crystalline powder<\/td>\n<\/tr>\n
Solubility<\/strong><\/td>\nSoluble in DMSO, sparingly soluble in methanol, practically insoluble in water<\/td>\n<\/tr>\n
Water<\/strong><\/td>\nMaximum 0.5%<\/td>\n<\/tr>\n
Specific optical rotation<\/strong><\/td>\n15 to 20<\/td>\n<\/tr>\n
Heavy metals<\/strong><\/td>\nMaximum 20 ppm<\/td>\n<\/tr>\n
Residue on ignition<\/strong><\/td>\nMaximum 0.1%<\/td>\n<\/tr>\n
Purity<\/strong><\/td>\nMinimum 99.7%<\/td>\n<\/tr>\n
Assay<\/strong><\/td>\n98.0% to 102.0% (dried substance)<\/td>\n<\/tr>\n
Storage<\/strong><\/td>\nPreserve in a well-closed container. Store at controlled room temperature<\/td>\n<\/tr>\n
Stability<\/strong><\/td>\nStable at least 2 years at room temperature<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Empagliflozin Grade Pharmaceutical Pharmacopoeia In house CAS No. 864070-44-0 Product Name Empagliflozin Chemical Name (2S,3R,4R,5S,6R)-2-[4-Chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol Function Active Pharmaceutical Ingredients (APIs) Industrial Application Pharmaceutical Category Antidiabetic type 2 General Description Empagliflozin is a medication used in the management and treatment of type 2 diabetes mellitus. It works in the kidneys to prevent the absorption of glucose […]<\/p>\n","protected":false},"author":1,"featured_media":970,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[136],"class_list":["post-1619","post","type-post","status-publish","format-standard","has-post-thumbnail","category-api","tag-empagliflozin-is-a-medication-used-in-the-management-and-treatment-of-type-2-diabetes-mellitus-it-works-in-the-kidneys-to-prevent"],"_links":{"self":[{"href":"https:\/\/paranddarou.co\/index.php\/wp-json\/wp\/v2\/posts\/1619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/paranddarou.co\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/paranddarou.co\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/paranddarou.co\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/paranddarou.co\/index.php\/wp-json\/wp\/v2\/comments?post=1619"}],"version-history":[{"count":3,"href":"https:\/\/paranddarou.co\/index.php\/wp-json\/wp\/v2\/posts\/1619\/revisions"}],"predecessor-version":[{"id":1712,"href":"https:\/\/paranddarou.co\/index.php\/wp-json\/wp\/v2\/posts\/1619\/revisions\/1712"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/paranddarou.co\/index.php\/wp-json\/wp\/v2\/media\/970"}],"wp:attachment":[{"href":"https:\/\/paranddarou.co\/index.php\/wp-json\/wp\/v2\/media?parent=1619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/paranddarou.co\/index.php\/wp-json\/wp\/v2\/categories?post=1619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/paranddarou.co\/index.php\/wp-json\/wp\/v2\/tags?post=1619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}